Medicaid AMPs Will Cut Average Pharmacy Revenue By Only 1 Percent – CMS
Executive Summary
Medicaid's average manufacturer price policy will save significant money for the government but the impact on the average pharmacy will be small, CMS concludes in evaluating the impact of its final AMP rules
You may also be interested in...
Medicaid drug bill introduced in Senate
The Fair Medicaid Payment Act of 2007, introduced Aug. 2 by Sen. Max Baucus, D-Mont., would remove mail-order transactions from the calculation of average manufacturer prices and exclude discounts, rebates and other price concessions that are not passed on to retail pharmacies. The bill, S. 1951, is being hailed by retail pharmacies as an improvement over the Medicaid drug reimbursement system created under the 2005 Deficit Reduction Act, because it uses a pricing benchmark based on acquisition costs and sets federal upper limits only when there are three or more, rather than two or more, equivalent drug products on the market. CMS recently issued its final rule establishing the AMP methodology (1"The Pink Sheet" July 23, 2007, p. 25). Similar legislation seeking to change the payment methodology was introduced in the House July 24 (2"The Pink Sheet" July 30, 2007, p. 22)...
Medicaid drug bill introduced in Senate
The Fair Medicaid Payment Act of 2007, introduced Aug. 2 by Sen. Max Baucus, D-Mont., would remove mail-order transactions from the calculation of average manufacturer prices and exclude discounts, rebates and other price concessions that are not passed on to retail pharmacies. The bill, S. 1951, is being hailed by retail pharmacies as an improvement over the Medicaid drug reimbursement system created under the 2005 Deficit Reduction Act, because it uses a pricing benchmark based on acquisition costs and sets federal upper limits only when there are three or more, rather than two or more, equivalent drug products on the market. CMS recently issued its final rule establishing the AMP methodology (1"The Pink Sheet" July 23, 2007, p. 25). Similar legislation seeking to change the payment methodology was introduced in the House July 24 (2"The Pink Sheet" July 30, 2007, p. 22)...
Medicaid Generic Dispensing Target Of 65% Proposed In Boyda/Emerson Bill
State Medicaid programs would be financially penalized if they fail to reach target levels of generic dispensing for multiple-source drugs, under Reps. Nancy Boyda, D-Kan., and Jo Ann Emerson's, R-Mo., legislation to overturn the average manufacturer price system